SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023608
Filing Date
2020-11-12
Accepted
2020-11-12 16:01:31
Documents
45
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctdh20200930_10q.htm 10-Q 490274
2 EXHIBIT 31.1 ex_213262.htm EX-31.1 14433
3 EXHIBIT 31.2 ex_213263.htm EX-31.2 14494
4 EXHIBIT 32.1 ex_213268.htm EX-32.1 5658
5 EXHIBIT 32.2 ex_213269.htm EX-32.2 5605
  Complete submission text file 0001437749-20-023608.txt   2638326

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctdh-20200930.xml EX-101.INS 377160
7 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20200930.xsd EX-101.SCH 32558
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctdh-20200930_cal.xml EX-101.CAL 30006
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20200930_def.xml EX-101.DEF 225594
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20200930_lab.xml EX-101.LAB 199113
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20200930_pre.xml EX-101.PRE 238234
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINSVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25466 | Film No.: 201306490
SIC: 2860 Industrial Organic Chemicals